Literature DB >> 24819290

Contact dermatitis to both tropicamide and phenylephrine eye drops.

Elisa Haroun-Díaz1, Mónica Ruíz-García, Sol De Luxán de la Lastra, Carlos Pastor-Vargas, Manuel De las Heras, Joaquín Sastre Domínguez, Javier Cuesta-Herranz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24819290     DOI： 10.1097/DER.0000000000000043

Source DB:  PubMed          Journal:  Dermatitis        ISSN： 1710-3568            Impact factor:   4.845


× No keyword cloud information.
  4 in total

1.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

2.  Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Authors:  Jacob Szpernal; Joseph Carroll; Ryan Spellecy; Jane A Bachman Groth
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-02       Impact factor: 1.742

3.  Pupillary Dilation in Research: More than Meets the Eye.

Authors:  Jacob Szpernal; Jane A Bachman Groth; Niamh Wynne; Vesper Williams; Ryan Spellecy; Catherine Thuruthumaly; Joseph Carroll
Journal:  Curr Eye Res       Date:  2022-05-02       Impact factor: 2.555

4.  Assessing the Clinical Requirement of 2.5% Phenylephrine for Diagnostic Pupil Examination.

Authors:  Junsang Cho; Brent Bruck; James C Liu; Susan M Culican
Journal:  J Ocul Pharmacol Ther       Date:  2021-03-08       Impact factor: 2.671
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.